Journal of Drug Metabolism & Toxicology
Open Access

Drug Interactions and Metabolism: How Different Drugs Affect Each Other

John Simpson^{* *}Correspondence: John Simpson, Department of Pharmacology, University of Central Florida, Orlando, USA, Email:

Author info »

Description

Drug metabolism is the process by which the body breaks down and eliminates foreign substances, such as drugs, from the body. This process involves a series of chemical reactions that transform the drug into a form that can be easily excreted from the body. Drug metabolism is an important process because it allows the body to eliminate drugs that may be harmful or toxic if they accumulate in the body. Drug metabolism occurs primarily in the liver, although other organs such as the kidneys, lungs, and intestines can also play a role. The liver is particularly important because it contains enzymes that are responsible for the majority of drug metabolism. These enzymes are located in the liver cells, or hepatocytes, and they are responsible for breaking down drugs into their metabolites.

There are two phases of drug metabolism: Phase I and Phase II. Phase I metabolism involves the introduction of a functional group into the drug molecule, such as hydroxylation, oxidation, or reduction. This makes the drug molecule more polar, which allows it to be excreted from the body more easily. Phase II metabolism involves the conjugation of the drug metabolite with an endogenous molecule, such as glucuronic acid, sulfate, or glutathione. This makes the metabolite even more polar, which further facilitates its excretion from the body. The cytochrome P450 enzymes are the most important enzymes involved in Phase I metabolism. These enzymes are located in the endoplasmic reticulum of the hepatocytes, and they are responsible for oxidizing drugs and other foreign substances. There are many different cytochrome P450 enzymes, each with different substrates and activities. The most important cytochrome P450 enzyme for drug metabolism is CYP3A4, which is responsible for the metabolism of approximately 50% of all drugs on the market. Phase II metabolism involves conjugation reactions, which are catalyzed by a variety of enzymes. The most important enzymes involved in Phase II metabolism are the UDPGlucuronosyltransferases (UGTs), which are responsible for the conjugation of drugs and drug metabolites with glucuronic acid. Other important conjugation enzymes include sulfotransferases, which are responsible for the conjugation of drugs with sulfate, and glutathione S-transferases, which are responsible for the conjugation of drugs with glutathione. Drug metabolism can be affected by a variety of factors, including genetics, age, gender, diet, and drug interactions. Genetic polymorphisms in drugmetabolizing enzymes can lead to variations in drug metabolism between individuals. For example, individuals with a genetic polymorphism in CYP2D6 may metabolize certain drugs more slowly than individuals without the polymorphism, which can lead to higher drug concentrations and an increased risk of adverse drug reactions.

Age can also affect drug metabolism, as the activity of some drugmetabolizing enzymes decreases with age. This can lead to a longer half-life for certain drugs in elderly individuals, which can increase the risk of adverse drug reactions. Gender can also affect drug metabolism, as some drug-metabolizing enzymes are more active in males than females. Diet can also affect drug metabolism, as certain foods and dietary supplements can induce or inhibit drug-metabolizing enzymes. For example, grapefruit juice can inhibit the activity of CYP3A4, which can lead to higher drug concentrations and an increased risk of adverse drug reactions. St. John's wort, on the other hand, can induce the activity of CYP3A4, which can lead to lower drug concentrations and decreased efficacy of certain drugs.